2025 SPS Seattle | Vutrisiran in the Wild-Type or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy

2025 SPS Seattle | Vutrisiran in the Wild-Type or Hereditary Transthyretin-Mediated Amyloidosis Cardiomyopathy

0% Complete

Course Overview

NA

Course Content

Course Details

Duration
0.00 hour
Released
Oct 5, 2025
Last Review
Oct 5, 2025
Expires
Oct 5, 2026

Objectives

NA

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE

Disclosure

<p>NA</p>

Accreditation

NA